Navigation Links
Pharmacyclics Reports Second Quarter 2014 Results
Date:7/31/2014

class="prnews_span">-15,415-100,190-150,259-Janssen's share of pre-tax profits

50%50%50%50%Total Cost of collaboration (Janssen's 50% share as per the Agreement)

$
50,095
$
-
$
75,130
$
-
Pharmacyclics' 50% share of net product revenue less cost of goods sold

$
50,095
$
-
$
75,130
$
-
(3)The Company's total share of net costs under the Agreement did not exceed the $50 million annual cap provided for in the Agreement. As such, no Excess Amounts were recorded for the three and six months ended June 30, 2014. Regulatory UpdateOn July 28, 2014, the U.S. FDA granted IMBRUVICA full approval for the treatment of CLL patients who have received at least one prior therapy, and for the treatment of CLL patients with deletion of the short arm of chromosome 17 (del 17p CLL), including treatment naive (frontline) and previously treated del 17p CLL patients. This was the first full FDA approval for IMBRUVICA, and was granted only five and a half months after the original accelerated approval for patients with previously treated CLL, which was granted in February 2014. 

This full approval is based on data from the Phase III RESONATE study (PCYC-1112-CA), a randomized, multi-center, international head-to-head comparison of single-agent, orally-administered IMBRUVICA (ibrutinib) versus the intravenous, monoclonal an
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine technology :

1. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014
2. Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
3. WuXi PharmaTech to Partner with Pharmacyclics
4. Pharmacyclics Reports Third Quarter 2013 Results
5. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
6. Pharmacyclics Reports Second Quarter 2013 Results
7. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
8. Pharmacyclics Reports First Quarter 2013 Results
9. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
10. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
11. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 2015 ViiV Healthcare, Aurobindo Pharma, ... today that Aurobindo Pharma has submitted an Abbreviated New ... to the Food and Drug Administration (FDA), for the ... a generic version of dolutegravir, less than two years ... the United States . ...
(Date:5/26/2015)... 26, 2015  LabStyle Innovations Corp. (DRIO), ... announced today that in partnership with ... Healthcare, it has launched  the comprehensive Dario™ ... advanced Telecare unit (MOMA). The Dario™ is ... enables remote treatment for diabetes aiming to ...
(Date:5/26/2015)... May 26, 2015  Respiratory Motion, Inc. – ... Annual Meeting of the Japanese Society of Anesthesiologists ... respiration in hospitals miss critical early indicators of ... The findings conclude that respiratory volume monitoring using ... more consistently protects patients than traditional capnography and ...
Breaking Medicine Technology:ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 3LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5
... DIEGO, Feb. 8, 2011 Anadys Pharmaceuticals, Inc. (Nasdaq: ... the 13th Annual Bio CEO & Investor Conference on Tuesday, ...  The conference is being held at the Waldorf-Astoria Hotel in ... Officer of Anadys, will provide an overview of Anadys and ...
... District of Columbia Patients Cooperative (DCPC), a taxable non-profit corporation ... affordable medical "marijuana" to qualifying DC patients will host a ... marijuana program.  The public meeting is open to members of ... at 7:00 pm in Pierce Hall at All Souls Unitarian ...
Cached Medicine Technology:Anadys Pharmaceuticals to Present at the Bio CEO & Investor Conference 2February 10 Town Hall Meeting to Explain DC's New Medical Marijuana Program 2
(Date:5/26/2015)... (PRWEB) May 26, 2015 Surging to ... one of the leading online health and wellness sites, ... to the online community. It has proven to ... to read articles, watch videos, ask questions and interact ... launch of the official Consumer Health Digest YouTube Channel ...
(Date:5/26/2015)... Tysons Corner, VA (PRWEB) May 26, 2015 ... mission critical technology and management consulting solutions to the ... of Technology Strategy and Cloud Solutions. In this newly ... firm’s strategic capabilities and growth in cloud computing, big ... GP join our expanding leadership team as we continue ...
(Date:5/26/2015)... Allprovide, the all-natural raw pet food ... foods are now available in three Georgia stores: Pooch-n-Paws ... Good Old Dog Company in Kennesaw. , Allprovide is ... a state-of-the-art, climate controlled facility. The fresh ingredients come ... of the food is triple-tested for quality. Unlike most ...
(Date:5/26/2015)... New Brunswick (PRWEB) May 26, 2015 ... announce the successful upgrade of the DMi Partners ... This version was the first in Indosoft's contact center ... API improvements, added screen support for such trunk features ... screens, improved lead management, and included upgrades to ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Texas Physical ... of its newest clinic on May 25, 2015 in San ... Rogers Road, Suite 102 in Westover Hills and offers appointments ... P.M. , “We’re thrilled about opening this new location ... of our neighbors in San Antonio and to show them ...
Breaking Medicine News(10 mins):Health News:Consumer Health Digest Official YouTube Channel: A Reliable Source of Health Information 2Health News:Octo Consulting Group (Octo) Appoints Gaurav “GP” Pal as Vice President of Technology Strategy and Cloud Solutions 2Health News:Allprovide, the All-Natural Pet Food, Available At Georgia Retailers 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:TexPTS Announces New Clinic in San Antonio 2
... higher rates of chronic disease than others, according to ... Health in conjunction with its Office of Women's ... report, which examined the relationship between ethnicity and women's ... from 8,600 residents randomly surveyed by telephone in 2005. ...
... Together, they form a difficult pair to beat . ... of Ohio University College of Osteopathic Medicine (OU-COM) and ... to the double-edged problem. Program ACTIVE (Appalachians Coming Together ... study to test the effectiveness of a combination of ...
... region already ravaged by poverty and inter-tribal tensions. ... against HIV/AIDS there terribly exhausting, almost fruitless, yet ... reduce the continuing, extraordinary HIV prevalence in Botswana and ... enforce women's legal rights," Karen Leiter, lead investigator ...
... the Middle East, said doctors from UAE who met in ... . ,However, the medical experts agreed that the ... longer, WAM news agency reported. ,The good news ... that breast cancer cases (in UAE) are being caught much ...
... Medicine and the Veterans Affairs Palo Alto Health Care System ... new- born deaths between 1991 and 2000 in California, could ... if they had been born in different hospitals. Risky deliveries ... would afford the best chance of survival for newborns, who ...
... of Advanced Nursing reports that many socially disadvantaged UK residents ... . ,A research across London by TB specialists ... trying to halt the spread of the disease. ... last 10 years and London is no exception" says lead ...
Cached Medicine News:Health News:Minority Women in LA County Have Higher Rates of Chronic Disease Than Whites 2Health News:Study Tests Depression Treatment for Diabetes Patients 2Health News:Study Tests Depression Treatment for Diabetes Patients 3Health News:Cultural Bias Against Women Hampering Fight Against AIDS in Africa 2Health News:Low Weight Newborns at Greater Risk in Community Hospitals 2Health News:Low Weight Newborns at Greater Risk in Community Hospitals 3Health News:TB Patients in Marginalised Groups Need Social Support for Effective Medical Treatment 2
The CIC Pro Clinical Information Center brings together vital patient information from multiple monitoring devices....
... Alaris System integrates drug infusion,with patient ... a single, modular platform. With multiple ... modules as you,need them, keeping the ... a minimum while managing the unique ...
... Gemini Family of infusion pumps ... a collective series of administration ... line offers a wide variety ... sets, each featuring the patented ...
... These specialty Eraser instruments have ... surgeon with the right tool for ... introduced a series of 25 gauge ... provide discrete treatment of target tissues ...
Medicine Products: